83 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 2 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x RNA TS TPMi x
ALPPL2Alkaline phosphatase, placental like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Plasma membraneTissue enhancedfallopian tube:1.5
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enrichedpancreas:31329.4
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Cytosol
Tissue enhancedadipose tissue:450.1
BCHEButyrylcholinesteraseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhancedliver:265.5
BGLAPBone gamma-carboxyglutamate proteinFDA approved drug targets
Predicted secreted proteins
Mixed
C1RComplement C1rDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Cytosol
Expressed in all
C1SComplement C1sDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleus
Cytosol
Expressed in all
C3Complement C3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
C4AComplement C4A (Rodgers blood group)Blood group antigen proteins
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhancedliver:46.1
C4BComplement C4B (Chido blood group)Blood group antigen proteins
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhancedadrenal gland:59.4
liver:65.5
C5Complement C5Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enrichedliver:225.6
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enrichedadrenal gland:132.5
CCL2C-C motif chemokine ligand 2Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Expressed in all
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulumGroup enrichedgallbladder:399.2
liver:1099.9
lung:229.9
CKMT1ACreatine kinase, mitochondrial 1AEnzymes
FDA approved drug targets
Predicted secreted proteins
Mixed
CKMT1BCreatine kinase, mitochondrial 1BEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhancedcolon:78.0
rectum:68.4
CYP17A1Cytochrome P450 family 17 subfamily A member 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enrichedadrenal gland:3751.4
DPEP1Dipeptidase 1 (renal)Enzymes
FDA approved drug targets
Predicted secreted proteins
Nucleus
Cell Junctions
Tissue enhancedkidney:262.6
small intestine:418.9
ELANEElastase, neutrophil expressedCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enrichedbone marrow:1199.6
F10Coagulation factor XCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhancedliver:67.5
F11Coagulation factor XICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhancedliver:180.1
F12Coagulation factor XIICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enrichedliver:141.6
F2Coagulation factor II, thrombinCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedliver:627.3
F5Coagulation factor VCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enrichedgallbladder:28.4
liver:93.7
placenta:68.2
F7Coagulation factor VIICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
MitochondriaTissue enrichedliver:65.0
F8Coagulation factor VIIICandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
F9Coagulation factor IXCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enrichedliver:365.0
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enrichedliver:9265.4
FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhancedplacenta:4284.3
GANABGlucosidase II alpha subunitDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nuclear membrane
Endoplasmic reticulum
Cytosol
Expressed in all
IDEInsulin degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
IFNGInterferon gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhancedappendix:4.7
bone marrow:7.6
lymph node:7.9
IL12BInterleukin 12BDisease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Not detected
IL17AInterleukin 17ACancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhancedappendix:1.0
tonsil:1.3
urinary bladder:1.5
IL23AInterleukin 23 subunit alphaFDA approved drug targets
Predicted secreted proteins
CytosolTissue enhancedtonsil:8.0
IL5Interleukin 5Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedtestis:9.6
IL6Interleukin 6Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhancedadipose tissue:136.4
KLKB1Kallikrein B1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enrichedliver:155.0
LIPFLipase F, gastric typeEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enrichedstomach:22415.5
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhancedadipose tissue:976.8
MMP1Matrix metallopeptidase 1Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enhancedappendix:39.2
gallbladder:126.4
MMP10Matrix metallopeptidase 10Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enrichedendometrium:443.1
MMP11Matrix metallopeptidase 11Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enrichedcervix, uterine:31.6
endometrium:123.1
placenta:28.0
MMP12Matrix metallopeptidase 12Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhancedappendix:54.6
urinary bladder:28.7
MMP13Matrix metallopeptidase 13Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhancedlung:1.5
urinary bladder:1.3
MMP17Matrix metallopeptidase 17Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhancedcerebral cortex:24.0
MMP19Matrix metallopeptidase 19Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Tissue enhancedadipose tissue:64.2
gallbladder:97.3
MMP2Matrix metallopeptidase 2Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Cytosol
Tissue enhancedgallbladder:1682.1
MMP20Matrix metallopeptidase 20Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enrichedtestis:1.1
MMP21Matrix metallopeptidase 21Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enrichedepididymis:59.2
Page of 2 | next »